ScinoPharm Taiwan reports Sep revenue of NT$309.4M
ScinoPharm Taiwan Ltd. reported September revenue of NT$309,439,000 versus NT$177,384,000 in 2025. Jan–Sep revenue was NT$2,032,302,000 versus NT$2,155,381,000 in 2025, according to Taiwan Stock Exchange figures.